-
RRMS treatments shown to be equally effective
Gilenya and Tecfidera are equally effective as first-line treatments in people with relapsing-remitting multiple sclerosis (RRMS), but Gilenya may be of slightly more benefit to those who switch from a previous injectable therapy, a real-world study of patients in Italy reports.
Read more about this research news here: Effectiveness of Gilenya and Tecfidera Compared in Real-World Study in Italy
Have you tried any of these medications? If so, which one and how did you find it? Did it work for you?
Sorry, there were no replies found.
Log in to reply.